Eggplant skin composition with hypoglycemic effect and its preparation method and application

Abstract

The invention provides an eggplant skin composition with hypoglycemic effect and its preparation method and application. The eggplant skin composition comprises the following components in parts by weight: 40-50 parts of solanum skin alcohol extract, mulberry alcohol 10-20 parts of extract, 10-20 parts of kudzu root alcohol extract and 10-20 parts of penicillary alcohol extract. The eggplant skin composition of the present invention fully exerts the biological activity of natural active substances, has a synergistic effect, has many action targets, and can be effective through mechanisms such as stimulating insulin release, increasing insulin sensitivity, inhibiting α-glucosidase, or increasing the utilization of peripheral sugars. play a role in lowering blood sugar. The eggplant skin composition of the invention has the advantages of lowering blood sugar, enhancing immunity, preventing and treating complications, and less toxic and side effects, and the raw materials used are cheap and easy to obtain, the production cost is low, and the health care value is great, which is good news for patients with hyperglycemia.

Description

technical field [0001] The present invention relates to the field of hypoglycemic drugs, more specifically, to an eggplant skin composition with hypoglycemic effect and its preparation method and application. Background technique [0002] Under normal circumstances, the human body can ensure the balance between the source and outlet of blood sugar through the two major regulatory systems of hormone regulation and nerve regulation, so that blood sugar can be maintained at a certain level. However, under the joint action of genetic factors (such as family history of diabetes) and environmental factors (such as unreasonable diet, obesity, etc.), the two major regulatory functions are disturbed, and blood sugar levels will rise. Diabetes is a disease easily caused by elevated blood sugar, which has become one of the main causes of death in humans. [0003] At present, the clinical treatment of diabetes adopts intravenous injection of human insulin analogs and oral hypoglycemic ...

AI Technical Summary

Problems solved by technology

[0003] At present, the clinical treatment of diabetes adopts intravenous injection of human insulin analogs and oral hypoglycemic drugs, but long-term use of the body is prone to adverse reactions such as hypoglycemia, insulin resistance and poor tolerance, resulting in poor blood sugar control and easy to cause acute cardiovascular disease. Occurrence of diseases and other events, and limited medication, unable to adapt to the current fast-paced life needs and continuously improving life taste